Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 03-2025 | 02-2025 | 11-2024 | 08-2024 | 05-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,769 | -37,570 | -22,801 | -16,230 | N/A |
| Depreciation Amortization | 2,076 | 6,113 | 4,037 | 1,993 | N/A |
| Income taxes - deferred | N/A | N/A | 9 | N/A | N/A |
| Accounts receivable | -3,231 | -602 | 1,000 | 6,075 | N/A |
| Accounts payable and accrued liabilities | -3,505 | -2,714 | 791 | 3,628 | N/A |
| Other Working Capital | -2,441 | -3,669 | -1,229 | 7,497 | N/A |
| Other Operating Activity | 23,069 | 32,889 | 11,440 | -3,576 | 0 |
| Operating Cash Flow | $1,199 | $-5,553 | $-6,753 | $-613 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,544 | -4,318 | -5,862 | -3,422 | N/A |
| Investing Cash Flow | $1,544 | $-4,318 | $-5,862 | $-3,422 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 27,893 | -17,191 | -11,191 | 31,824 | N/A |
| Debt Issued | N/A | 2,400 | 2,400 | N/A | N/A |
| Debt Repayment | N/A | -699 | -468 | -233 | N/A |
| Common Stock Issued | N/A | 23,858 | 23,841 | 1 | N/A |
| Other Financing Activity | -34,676 | -1,542 | -974 | -30,499 | 0 |
| Financing Cash Flow | $-6,783 | $6,826 | $13,608 | $1,093 | $N/A |
| Beginning Cash Position | 9,455 | 8,462 | 8,462 | 8,462 | N/A |
| End Cash Position | 5,415 | 5,417 | 9,455 | 5,520 | N/A |
| Net Cash Flow | $-4,040 | $-3,045 | $993 | $-2,942 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,199 | -5,553 | -6,753 | -613 | N/A |
| Capital Expenditure | -5,456 | -11,318 | -5,862 | -3,422 | N/A |
| Free Cash Flow | -4,257 | -16,871 | -12,615 | -4,035 | 0 |